During the acute COVID-19, detection of aPL (LA, IgG and IgM aCL, IgG and IgM aβ2GPI) was performed in 114 patients who had at least one follow-up visit more than 3 months after the acute COVID-19 (Table 1). The gene discussed is ACLY; the disease is COVID-19.